Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.
Espinosa
G
G
Systemic Autoimmune Diseases Unit, Institut Clínic d'Infeccions i Immunologia, August Pi i Sunyer, Hospital Clínic, Barcelona, Spain.
Font
J
J
García-Pagan
J C
JC
Tàssies
D
D
Reverter
J C
JC
Gaig
C
C
Cervantes
F
F
Cervera
R
R
Bosch
J
J
Ingelmo
M
M
D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications*; D015415:Biomarkers; D006502:Budd-Chiari Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D015984:Causality; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000925:Anticoagulants; D015415:Biomarkers